Research Article
Peripheral Blood Occludin Level as a Biomarker for Perioperative Cerebral Edema in Patients with Brain Tumors
Table 1
Baseline clinical characteristics of the study participants.
| Characteristic | Patients with brain tumors () | Healthy volunteers () | |
| Age (years) | | | 0.074 | Female | 31 (56.4%) | 13 (51.2%) | 0.857 | Tumor location | | | | Frontal lobe | 15 (27.3%) | N/A | N/A | Temporal lobe | 14 (25.5%) | N/A | N/A | Occipital lobe | 6 (10.9%) | N/A | N/A | Parietal lobe | 3 (5.5%) | N/A | N/A | Sella region | 6 (10.9%) | N/A | N/A | Cerebellum | 4 (7.3%) | N/A | N/A | Brain stem | 5 (9.1%) | N/A | N/A | Basal ganglia | 2 (3.6%) | N/A | N/A | Tumor pathology | | | | Glioma | 22 (40.0%) | N/A | N/A | Meningioma | 12 (21.8%) | N/A | N/A | Neurilemmoma | 7 (12.7%) | N/A | N/A | Hypophysoma | 4 (7.3%) | N/A | N/A | Hemangioma | 4 (7.3%) | N/A | N/A | Germinoma | 2 (3.6%) | N/A | N/A | Craniopharyngioma | 2 (3.6%) | N/A | N/A | Chordoma | 1 (1.8%) | N/A | N/A | Cholesteatoma | 1 (1.8%) | N/A | N/A |
|
|
Data are presented as or (%). N/A: not applicable. |